[Rheumatoid factors during controlled krizanol treatment of rheumatoid arthritis patients].
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000000981:diagnostic imaging / Q000188:drug therapy; D001175:Arthrography; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004112:Dimercaprol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006046:Gold / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D050607:Organogold Compounds; D009942:Organometallic Compounds; D020005:Propanols; D012217:Rheumatoid Factor / Q000032:analysis*; D013438:Sulfhydryl Compounds; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D050607:Organogold Compounds; D009942:Organometallic Compounds; D020005:Propanols; D013438:Sulfhydryl Compounds; D004112:Dimercaprol; D006046:Gold; D012217:Rheumatoid Factor; C013394:aurotioprol
Revmatoidnye faktory pri kontroliruemom lechenii krizanolom bol'nykh revmatoidnym artritom.